Literature DB >> 28674681

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer.

Peter C Rowe1, Rosemary A Underhill2, Kenneth J Friedman3, Alan Gurwitt4, Marvin S Medow5, Malcolm S Schwartz6, Nigel Speight7, Julian M Stewart8, Rosamund Vallings9, Katherine S Rowe10.   

Abstract

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disease that affects children and adolescents as well as adults. The etiology has not been established. While many pediatricians and other health-care providers are aware of ME/CFS, they often lack essential knowledge that is necessary for diagnosis and treatment. Many young patients experience symptoms for years before receiving a diagnosis. This primer, written by the International Writing Group for Pediatric ME/CFS, provides information necessary to understand, diagnose, and manage the symptoms of ME/CFS in children and adolescents. ME/CFS is characterized by overwhelming fatigue with a substantial loss of physical and mental stamina. Cardinal features are malaise and a worsening of symptoms following minimal physical or mental exertion. These post-exertional symptoms can persist for hours, days, or weeks and are not relieved by rest or sleep. Other symptoms include cognitive problems, unrefreshing or disturbed sleep, generalized or localized pain, lightheadedness, and additional symptoms in multiple organ systems. While some young patients can attend school, on a full or part-time basis, many others are wheelchair dependent, housebound, or bedbound. Prevalence estimates for pediatric ME/CFS vary from 0.1 to 0.5%. Because there is no diagnostic test for ME/CFS, diagnosis is purely clinical, based on the history and the exclusion of other fatiguing illnesses by physical examination and medical testing. Co-existing medical conditions including orthostatic intolerance (OI) are common. Successful management is based on determining the optimum balance of rest and activity to help prevent post-exertional symptom worsening. Medications are helpful to treat pain, insomnia, OI and other symptoms. The published literature on ME/CFS and specifically that describing the diagnosis and management of pediatric ME/CFS is very limited. Where published studies are lacking, recommendations are based on the clinical observations and practices of the authors.

Entities:  

Keywords:  adolescent; chronic fatigue syndrome; diagnosis; joint hypermobility; management; myalgic encephalomyelitis; pediatric; postural tachycardia syndrome

Year:  2017        PMID: 28674681      PMCID: PMC5474682          DOI: 10.3389/fped.2017.00121

Source DB:  PubMed          Journal:  Front Pediatr        ISSN: 2296-2360            Impact factor:   3.418


  173 in total

Review 1.  Evidence for the presence of immune dysfunction in chronic fatigue syndrome.

Authors:  Benjamin H Natelson; Mohammad H Haghighi; Nicholas M Ponzio
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

2.  Risk factors associated with chronic fatigue syndrome in a cluster of pediatric cases.

Authors:  K M Bell; D Cookfair; D S Bell; P Reese; L Cooper
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

3.  What to do about attention and memory problems in children with CFS/ME: a neuropsychological approach.

Authors:  Peter Tucker; Andrew Haig-Ferguson; Nicola Eaton; Esther Crawley
Journal:  Clin Child Psychol Psychiatry       Date:  2011-04       Impact factor: 2.544

4.  Impaired postural cerebral hemodynamics in young patients with chronic fatigue with and without orthostatic intolerance.

Authors:  Hidetaka Tanaka; Reiko Matsushima; Hiroshi Tamai; Yoshinaga Kajimoto
Journal:  J Pediatr       Date:  2002-04       Impact factor: 4.406

5.  Diagnosing postural tachycardia syndrome: comparison of tilt testing compared with standing haemodynamics.

Authors:  Walker B Plash; André Diedrich; Italo Biaggioni; Emily M Garland; Sachin Y Paranjape; Bonnie K Black; William D Dupont; Satish R Raj
Journal:  Clin Sci (Lond)       Date:  2013-01       Impact factor: 6.124

6.  Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial.

Authors:  S E Straus; J K Dale; M Tobi; T Lawley; O Preble; R M Blaese; C Hallahan; W Henle
Journal:  N Engl J Med       Date:  1988-12-29       Impact factor: 91.245

7.  Sympathetic predominance of cardiovascular regulation during mild orthostatic stress in adolescents with chronic fatigue.

Authors:  Vegard B Wyller; J P Saul; Jan P Amlie; Erik Thaulow
Journal:  Clin Physiol Funct Imaging       Date:  2007-07       Impact factor: 2.273

8.  Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis.

Authors:  Jonathan R Kerr; Robert Petty; Beverley Burke; John Gough; David Fear; Lindsey I Sinclair; Derek L Mattey; Selwyn C M Richards; Jane Montgomery; Don A Baldwin; Paul Kellam; Tim J Harrison; George E Griffin; Janice Main; Derek Enlander; David J Nutt; Stephen T Holgate
Journal:  J Infect Dis       Date:  2008-04-15       Impact factor: 5.226

9.  Cognitive functioning in chronic fatigue syndrome: a meta-analysis.

Authors:  S J Cockshell; J L Mathias
Journal:  Psychol Med       Date:  2010-01-05       Impact factor: 7.723

10.  Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO₂peak indicates functional impairment.

Authors:  Betsy A Keller; John Luke Pryor; Ludovic Giloteaux
Journal:  J Transl Med       Date:  2014-04-23       Impact factor: 5.531

View more
  38 in total

1.  Approaching recovery from myalgic encephalomyelitis and chronic fatigue syndrome: Challenges to consider in research and practice.

Authors:  Andrew R Devendorf; Carly T Jackson; Madison Sunnquist; Leonard A Jason
Journal:  J Health Psychol       Date:  2017-11-28

2.  Orthostatic Challenge Causes Distinctive Symptomatic, Hemodynamic and Cognitive Responses in Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Suzanne D Vernon; Sherlyn Funk; Lucinda Bateman; Gregory J Stoddard; Sarah Hammer; Karen Sullivan; Jennifer Bell; Saeed Abbaszadeh; W Ian Lipkin; Anthony L Komaroff
Journal:  Front Med (Lausanne)       Date:  2022-06-23

Review 3.  The Role of Kynurenine Pathway and NAD+ Metabolism in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Mona Dehhaghi; Hamed Kazemi Shariat Panahi; Bahar Kavyani; Benjamin Heng; Vanessa Tan; Nady Braidy; Gilles J Guillemin
Journal:  Aging Dis       Date:  2022-06-01       Impact factor: 9.968

4.  Patients' hopes for recovery from myalgic encephalomyelitis and chronic fatigue syndrome: Toward a "recovery in" framework.

Authors:  Andrew R Devendorf; Abigail A Rown; Leonard A Jason
Journal:  Chronic Illn       Date:  2018-12-06

5.  European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe.

Authors:  Luis Nacul; François Jérôme Authier; Carmen Scheibenbogen; Lorenzo Lorusso; Ingrid Bergliot Helland; Jose Alegre Martin; Carmen Adella Sirbu; Anne Marit Mengshoel; Olli Polo; Uta Behrends; Henrik Nielsen; Patricia Grabowski; Slobodan Sekulic; Nuno Sepulveda; Fernando Estévez-López; Pawel Zalewski; Derek F H Pheby; Jesus Castro-Marrero; Giorgos K Sakkas; Enrica Capelli; Ivan Brundsdlund; John Cullinan; Angelika Krumina; Jonas Bergquist; Modra Murovska; Ruud C W Vermuelen; Eliana M Lacerda
Journal:  Medicina (Kaunas)       Date:  2021-05-19       Impact factor: 2.430

6.  The Prevalence of Pediatric Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in a Community‑Based Sample.

Authors:  Leonard A Jason; Ben Z Katz; Madison Sunnquist; Chelsea Torres; Joseph Cotler; Shaun Bhatia
Journal:  Child Youth Care Forum       Date:  2020-01-23

Review 7.  Elements of Suffering in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Experience of Loss, Grief, Stigma, and Trauma in the Severely and Very Severely Affected.

Authors:  Patricia A Fennell; Nancy Dorr; Shane S George
Journal:  Healthcare (Basel)       Date:  2021-05-09

Review 8.  The Impact of Severe ME/CFS on Student Learning and K-12 Educational Limitations.

Authors:  Faith R Newton
Journal:  Healthcare (Basel)       Date:  2021-05-25

9.  Improvement of severe myalgic encephalomyelitis/chronic fatigue syndrome symptoms following surgical treatment of cervical spinal stenosis.

Authors:  Peter C Rowe; Colleen L Marden; Scott Heinlein; Charles C Edwards
Journal:  J Transl Med       Date:  2018-02-02       Impact factor: 5.531

10.  A preliminary investigation of nutritional intake and supplement use in Australians with myalgic encephalomyelitis/chronic fatigue syndrome and the implications on health-related quality of life.

Authors:  Breanna Weigel; Natalie Eaton-Fitch; Rachel Passmore; Hélène Cabanas; Donald Staines; Sonya Marshall-Gradisnik
Journal:  Food Nutr Res       Date:  2021-06-07       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.